These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

184 related items for PubMed ID: 32054451

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Identification of Reversible Disruption of the Human Blood-Brain Barrier Following Acute Ischemia.
    Simpkins AN, Dias C, Leigh R, National Institutes of Health Natural History of Stroke Investigators.
    Stroke; 2016 Sep; 47(9):2405-8. PubMed ID: 27462115
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Canonical Wnt Pathway Maintains Blood-Brain Barrier Integrity upon Ischemic Stroke and Its Activation Ameliorates Tissue Plasminogen Activator Therapy.
    Jean LeBlanc N, Menet R, Picard K, Parent G, Tremblay MÈ, ElAli A.
    Mol Neurobiol; 2019 Sep; 56(9):6521-6538. PubMed ID: 30852795
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Pinocembrin Protects Blood-Brain Barrier Function and Expands the Therapeutic Time Window for Tissue-Type Plasminogen Activator Treatment in a Rat Thromboembolic Stroke Model.
    Ma Y, Li L, Kong L, Zhu Z, Zhang W, Song J, Chang J, Du G.
    Biomed Res Int; 2018 Sep; 2018():8943210. PubMed ID: 29850586
    [Abstract] [Full Text] [Related]

  • 8. Transient brain hypothermia reduces the reperfusion injury of delayed tissue plasminogen activator and extends its therapeutic time window in a focal embolic stroke model.
    Zarisfi M, Allahtavakoli F, Hassanipour M, Khaksari M, Rezazadeh H, Allahtavakoli M, Taghavi MM.
    Brain Res Bull; 2017 Sep; 134():85-90. PubMed ID: 28710023
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Should we exclude acute stroke patients with previous intracerebral hemorrhage from receiving intravenous thrombolysis?
    Lee SH, Kim BJ, Han MK, Park TH, Lee KB, Lee BC, Yu KH, Oh MS, Cha JK, Kim DH, Nah HW, Lee J, Lee SJ, Ko Y, Kim JG, Park JM, Kang K, Cho YJ, Hong KS, Choi JC, Kim JT, Choi K, Kim DE, Ryu WS, Kim WJ, Shin DI, Yeo M, Lee J, Lee JS, Gorelick PB, Bae HJ.
    Int J Stroke; 2016 Oct; 11(7):783-90. PubMed ID: 27312681
    [Abstract] [Full Text] [Related]

  • 11. Adjuvant treatment with neuroserpin increases the therapeutic window for tissue-type plasminogen activator administration in a rat model of embolic stroke.
    Zhang Z, Zhang L, Yepes M, Jiang Q, Li Q, Arniego P, Coleman TA, Lawrence DA, Chopp M.
    Circulation; 2002 Aug 06; 106(6):740-5. PubMed ID: 12163437
    [Abstract] [Full Text] [Related]

  • 12. Blood-brain barrier disruption is associated with increased mortality after endovascular therapy.
    Desilles JP, Rouchaud A, Labreuche J, Meseguer E, Laissy JP, Serfaty JM, Lapergue B, Klein IF, Guidoux C, Cabrejo L, Sirimarco G, Lavallée PC, Schouman-Claeys E, Amarenco P, Mazighi M.
    Neurology; 2013 Feb 26; 80(9):844-51. PubMed ID: 23365060
    [Abstract] [Full Text] [Related]

  • 13. Trial design and reporting standards for intra-arterial cerebral thrombolysis for acute ischemic stroke.
    Higashida RT, Furlan AJ, Roberts H, Tomsick T, Connors B, Barr J, Dillon W, Warach S, Broderick J, Tilley B, Sacks D, Technology Assessment Committee of the American Society of Interventional and Therapeutic Neuroradiology, Technology Assessment Committee of the Society of Interventional Radiology.
    Stroke; 2003 Aug 26; 34(8):e109-37. PubMed ID: 12869717
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Cell permeable HMGB1-binding heptamer peptide ameliorates neurovascular complications associated with thrombolytic therapy in rats with transient ischemic stroke.
    Li M, Chen S, Shi X, Lyu C, Zhang Y, Tan M, Wang C, Zang N, Liu X, Hu Y, Shen J, Zhou L, Gu Y.
    J Neuroinflammation; 2018 Aug 23; 15(1):237. PubMed ID: 30139371
    [Abstract] [Full Text] [Related]

  • 16. Utilization of intravenous thrombolysis in 3-4.5 hours: analysis of the Minnesota stroke registry.
    Tekle WG, Chaudhry SA, Hassan AE, Peacock JM, Lakshminarayan K, Tsai A, Luepker R, Anderson DC, Qureshi AI.
    Cerebrovasc Dis; 2012 Aug 23; 34(5-6):400-5. PubMed ID: 23221276
    [Abstract] [Full Text] [Related]

  • 17. Application of albumin prior to delayed thrombolysis reduces brain edema and blood brain barrier permeability in an embolic stroke model.
    Lu HT, Zhao JG, Li MH, Li YD.
    Brain Res; 2012 Feb 15; 1438():75-84. PubMed ID: 22227456
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Early blood-brain barrier disruption in human focal brain ischemia.
    Latour LL, Kang DW, Ezzeddine MA, Chalela JA, Warach S.
    Ann Neurol; 2004 Oct 15; 56(4):468-77. PubMed ID: 15389899
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.